ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transthyretin Stabilizer Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-36I12632
Home | Market Reports | Health| Pharmacy
Global Transthyretin Stabilizer Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Transthyretin Stabilizer Market Research Report 2025

Code: QYRE-Auto-36I12632
Report
March 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Merck
Astrazeneca plc
GlaxoSmithKline PLC
Corino Therapeutics, Inc
Alnylam Pharmaceuticals
BELLUS Health Inc
Ionis Pharmaceuticals Inc
Proclara Bioscience
Prothena Corporation Plc
Arturus Therapeutics

Transthyretin Stabilizer Market Size

The global market for Transthyretin Stabilizer was valued at US$ 1689 million in the year 2024 and is projected to reach a revised size of US$ 2677 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Transthyretin Stabilizer Market

Transthyretin Stabilizer Market

Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.A transthyretin (TTR) stabilizer is a type of medication or compound that is used in the treatment of transthyretin amyloidosis (ATTR), a rare genetic disorder characterized by the deposition of abnormal TTR protein in various organs and tissues.
TTR stabilizers work by binding to and stabilizing the TTR protein, preventing it from misfolding and forming amyloid fibrils. By stabilizing the TTR protein, these medications aim to slow down or halt the progression of the disease and potentially alleviate symptoms.
The global transthyretin stabilizer market refers to the market for medications and compounds used in the treatment of transthyretin amyloidosis (ATTR) by stabilizing the transthyretin (TTR) protein. This market encompasses various drugs that have been developed or under development as TTR stabilizers.
Currently, there are several TTR stabilizers that have gained regulatory approval or are in advanced stages of clinical development. The market is primarily driven by the rising prevalence of ATTR, increasing awareness of the disease, and the need for effective treatment options.
One of the key drugs in the market is tafamidis, which is approved in several countries for the treatment of ATTR polyneuropathy. Tafamidis has shown to stabilize TTR and slow disease progression in clinical trials. Other drugs such as diflunisal, AG10, inotersen, and patisiran are also being investigated and have shown promising results in clinical studies.
The market is expected to witness significant growth as more research is conducted on the development of TTR stabilizers and as regulatory approvals are obtained for these drugs in different regions. Additionally, the ongoing efforts to increase disease awareness among healthcare professionals and patients are likely to contribute to the market growth.
Key players in the global transthyretin stabilizer market include pharmaceutical companies such as Pfizer Inc., Alnylam Pharmaceuticals, Inc., Eidos Therapeutics, and Ionis Pharmaceuticals Inc., among others. These companies invest in research and development activities to develop new TTR stabilizers and expand their product portfolios.
Geographically, North America and Europe are leading regions in the market, primarily due to the higher prevalence of ATTR and the presence of established healthcare infrastructure. However, as awareness and diagnosis of ATTR improve in other regions such as Asia Pacific and Latin America, these regions are likely to exhibit significant growth opportunities.
In conclusion, the global transthyretin stabilizer market is expected to grow as more effective treatments are developed and approved for ATTR. The market is driven by the increasing prevalence of the disease and the need for therapies that can stabilize the TTR protein and slow disease progression.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transthyretin Stabilizer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin Stabilizer.
The Transthyretin Stabilizer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transthyretin Stabilizer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transthyretin Stabilizer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Transthyretin Stabilizer Market Report

Report Metric Details
Report Name Transthyretin Stabilizer Market
Accounted market size in year US$ 1689 million
Forecasted market size in 2031 US$ 2677 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Diflunisal
  • Tafamidis
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer Inc., Merck & Co., AstraZeneca Plc., GlaxoSmithKline Plc., Corino Therapeutics Inc., Alnylam Pharmaceuticals, Bellus Health Inc., Ionis Pharmaceuticals, Inc., Proclara Bioscience, Arturus Therapeutics, Prothena Corporation Plc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Transthyretin Stabilizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Transthyretin Stabilizer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Transthyretin Stabilizer Market growing?

Ans: The Transthyretin Stabilizer Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Transthyretin Stabilizer Market size in 2031?

Ans: The Transthyretin Stabilizer Market size in 2031 will be US$ 2677 million.

Who are the main players in the Transthyretin Stabilizer Market report?

Ans: The main players in the Transthyretin Stabilizer Market are Pfizer Inc., Merck & Co., AstraZeneca Plc., GlaxoSmithKline Plc., Corino Therapeutics Inc., Alnylam Pharmaceuticals, Bellus Health Inc., Ionis Pharmaceuticals, Inc., Proclara Bioscience, Arturus Therapeutics, Prothena Corporation Plc.

What are the Application segmentation covered in the Transthyretin Stabilizer Market report?

Ans: The Applications covered in the Transthyretin Stabilizer Market report are Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others

What are the Type segmentation covered in the Transthyretin Stabilizer Market report?

Ans: The Types covered in the Transthyretin Stabilizer Market report are Diflunisal, Tafamidis, Others

Recommended Reports

Neurodegenerative Disorders

Protein Stabilization

Rare Disease Therapeutics

1 Transthyretin Stabilizer Market Overview
1.1 Product Definition
1.2 Transthyretin Stabilizer by Type
1.2.1 Global Transthyretin Stabilizer Market Value Comparison by Type (2024 VS 2031)
1.2.2 Diflunisal
1.2.3 Tafamidis
1.2.4 Others
1.3 Transthyretin Stabilizer by Application
1.3.1 Global Transthyretin Stabilizer Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Pharmacies
1.3.6 Others
1.4 Global Transthyretin Stabilizer Market Size Estimates and Forecasts
1.4.1 Global Transthyretin Stabilizer Revenue 2020-2031
1.4.2 Global Transthyretin Stabilizer Sales 2020-2031
1.4.3 Global Transthyretin Stabilizer Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Transthyretin Stabilizer Market Competition by Manufacturers
2.1 Global Transthyretin Stabilizer Sales Market Share by Manufacturers (2020-2025)
2.2 Global Transthyretin Stabilizer Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Transthyretin Stabilizer Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Transthyretin Stabilizer, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transthyretin Stabilizer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transthyretin Stabilizer, Product Type & Application
2.7 Global Key Manufacturers of Transthyretin Stabilizer, Date of Enter into This Industry
2.8 Global Transthyretin Stabilizer Market Competitive Situation and Trends
2.8.1 Global Transthyretin Stabilizer Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transthyretin Stabilizer Players Market Share by Revenue
2.8.3 Global Transthyretin Stabilizer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transthyretin Stabilizer Market Scenario by Region
3.1 Global Transthyretin Stabilizer Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Transthyretin Stabilizer Sales by Region: 2020-2031
3.2.1 Global Transthyretin Stabilizer Sales by Region: 2020-2025
3.2.2 Global Transthyretin Stabilizer Sales by Region: 2026-2031
3.3 Global Transthyretin Stabilizer Revenue by Region: 2020-2031
3.3.1 Global Transthyretin Stabilizer Revenue by Region: 2020-2025
3.3.2 Global Transthyretin Stabilizer Revenue by Region: 2026-2031
3.4 North America Transthyretin Stabilizer Market Facts & Figures by Country
3.4.1 North America Transthyretin Stabilizer Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Transthyretin Stabilizer Sales by Country (2020-2031)
3.4.3 North America Transthyretin Stabilizer Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transthyretin Stabilizer Market Facts & Figures by Country
3.5.1 Europe Transthyretin Stabilizer Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Transthyretin Stabilizer Sales by Country (2020-2031)
3.5.3 Europe Transthyretin Stabilizer Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transthyretin Stabilizer Market Facts & Figures by Region
3.6.1 Asia Pacific Transthyretin Stabilizer Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Transthyretin Stabilizer Sales by Region (2020-2031)
3.6.3 Asia Pacific Transthyretin Stabilizer Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transthyretin Stabilizer Market Facts & Figures by Country
3.7.1 Latin America Transthyretin Stabilizer Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Transthyretin Stabilizer Sales by Country (2020-2031)
3.7.3 Latin America Transthyretin Stabilizer Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transthyretin Stabilizer Market Facts & Figures by Country
3.8.1 Middle East and Africa Transthyretin Stabilizer Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Transthyretin Stabilizer Sales by Country (2020-2031)
3.8.3 Middle East and Africa Transthyretin Stabilizer Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Transthyretin Stabilizer Sales by Type (2020-2031)
4.1.1 Global Transthyretin Stabilizer Sales by Type (2020-2025)
4.1.2 Global Transthyretin Stabilizer Sales by Type (2026-2031)
4.1.3 Global Transthyretin Stabilizer Sales Market Share by Type (2020-2031)
4.2 Global Transthyretin Stabilizer Revenue by Type (2020-2031)
4.2.1 Global Transthyretin Stabilizer Revenue by Type (2020-2025)
4.2.2 Global Transthyretin Stabilizer Revenue by Type (2026-2031)
4.2.3 Global Transthyretin Stabilizer Revenue Market Share by Type (2020-2031)
4.3 Global Transthyretin Stabilizer Price by Type (2020-2031)
5 Segment by Application
5.1 Global Transthyretin Stabilizer Sales by Application (2020-2031)
5.1.1 Global Transthyretin Stabilizer Sales by Application (2020-2025)
5.1.2 Global Transthyretin Stabilizer Sales by Application (2026-2031)
5.1.3 Global Transthyretin Stabilizer Sales Market Share by Application (2020-2031)
5.2 Global Transthyretin Stabilizer Revenue by Application (2020-2031)
5.2.1 Global Transthyretin Stabilizer Revenue by Application (2020-2025)
5.2.2 Global Transthyretin Stabilizer Revenue by Application (2026-2031)
5.2.3 Global Transthyretin Stabilizer Revenue Market Share by Application (2020-2031)
5.3 Global Transthyretin Stabilizer Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Company Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc. Transthyretin Stabilizer Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Merck & Co.
6.2.1 Merck & Co. Company Information
6.2.2 Merck & Co. Description and Business Overview
6.2.3 Merck & Co. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck & Co. Transthyretin Stabilizer Product Portfolio
6.2.5 Merck & Co. Recent Developments/Updates
6.3 AstraZeneca Plc.
6.3.1 AstraZeneca Plc. Company Information
6.3.2 AstraZeneca Plc. Description and Business Overview
6.3.3 AstraZeneca Plc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Plc. Transthyretin Stabilizer Product Portfolio
6.3.5 AstraZeneca Plc. Recent Developments/Updates
6.4 GlaxoSmithKline Plc.
6.4.1 GlaxoSmithKline Plc. Company Information
6.4.2 GlaxoSmithKline Plc. Description and Business Overview
6.4.3 GlaxoSmithKline Plc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GlaxoSmithKline Plc. Transthyretin Stabilizer Product Portfolio
6.4.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.5 Corino Therapeutics Inc.
6.5.1 Corino Therapeutics Inc. Company Information
6.5.2 Corino Therapeutics Inc. Description and Business Overview
6.5.3 Corino Therapeutics Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Corino Therapeutics Inc. Transthyretin Stabilizer Product Portfolio
6.5.5 Corino Therapeutics Inc. Recent Developments/Updates
6.6 Alnylam Pharmaceuticals
6.6.1 Alnylam Pharmaceuticals Company Information
6.6.2 Alnylam Pharmaceuticals Description and Business Overview
6.6.3 Alnylam Pharmaceuticals Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alnylam Pharmaceuticals Transthyretin Stabilizer Product Portfolio
6.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
6.7 Bellus Health Inc.
6.7.1 Bellus Health Inc. Company Information
6.7.2 Bellus Health Inc. Description and Business Overview
6.7.3 Bellus Health Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bellus Health Inc. Transthyretin Stabilizer Product Portfolio
6.7.5 Bellus Health Inc. Recent Developments/Updates
6.8 Ionis Pharmaceuticals, Inc.
6.8.1 Ionis Pharmaceuticals, Inc. Company Information
6.8.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
6.8.3 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Portfolio
6.8.5 Ionis Pharmaceuticals, Inc. Recent Developments/Updates
6.9 Proclara Bioscience
6.9.1 Proclara Bioscience Company Information
6.9.2 Proclara Bioscience Description and Business Overview
6.9.3 Proclara Bioscience Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Proclara Bioscience Transthyretin Stabilizer Product Portfolio
6.9.5 Proclara Bioscience Recent Developments/Updates
6.10 Arturus Therapeutics
6.10.1 Arturus Therapeutics Company Information
6.10.2 Arturus Therapeutics Description and Business Overview
6.10.3 Arturus Therapeutics Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Arturus Therapeutics Transthyretin Stabilizer Product Portfolio
6.10.5 Arturus Therapeutics Recent Developments/Updates
6.11 Prothena Corporation Plc.
6.11.1 Prothena Corporation Plc. Company Information
6.11.2 Prothena Corporation Plc. Description and Business Overview
6.11.3 Prothena Corporation Plc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Prothena Corporation Plc. Transthyretin Stabilizer Product Portfolio
6.11.5 Prothena Corporation Plc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transthyretin Stabilizer Industry Chain Analysis
7.2 Transthyretin Stabilizer Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transthyretin Stabilizer Production Mode & Process Analysis
7.4 Transthyretin Stabilizer Sales and Marketing
7.4.1 Transthyretin Stabilizer Sales Channels
7.4.2 Transthyretin Stabilizer Distributors
7.5 Transthyretin Stabilizer Customer Analysis
8 Transthyretin Stabilizer Market Dynamics
8.1 Transthyretin Stabilizer Industry Trends
8.2 Transthyretin Stabilizer Market Drivers
8.3 Transthyretin Stabilizer Market Challenges
8.4 Transthyretin Stabilizer Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Merck
Astrazeneca plc
GlaxoSmithKline PLC
Corino Therapeutics, Inc
Alnylam Pharmaceuticals
BELLUS Health Inc
Ionis Pharmaceuticals Inc
Proclara Bioscience
Prothena Corporation Plc
Arturus Therapeutics
List of Tables
 Table 1. Global Transthyretin Stabilizer Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Transthyretin Stabilizer Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Transthyretin Stabilizer Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Transthyretin Stabilizer Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Transthyretin Stabilizer Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Transthyretin Stabilizer Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Transthyretin Stabilizer Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Transthyretin Stabilizer Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Transthyretin Stabilizer, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Transthyretin Stabilizer, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Transthyretin Stabilizer, Product Type & Application
 Table 12. Global Key Manufacturers of Transthyretin Stabilizer, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Transthyretin Stabilizer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Stabilizer as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Transthyretin Stabilizer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Transthyretin Stabilizer Sales by Region (2020-2025) & (K Units)
 Table 18. Global Transthyretin Stabilizer Sales Market Share by Region (2020-2025)
 Table 19. Global Transthyretin Stabilizer Sales by Region (2026-2031) & (K Units)
 Table 20. Global Transthyretin Stabilizer Sales Market Share by Region (2026-2031)
 Table 21. Global Transthyretin Stabilizer Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Transthyretin Stabilizer Revenue Market Share by Region (2020-2025)
 Table 23. Global Transthyretin Stabilizer Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Transthyretin Stabilizer Revenue Market Share by Region (2026-2031)
 Table 25. North America Transthyretin Stabilizer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Transthyretin Stabilizer Sales by Country (2020-2025) & (K Units)
 Table 27. North America Transthyretin Stabilizer Sales by Country (2026-2031) & (K Units)
 Table 28. North America Transthyretin Stabilizer Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Transthyretin Stabilizer Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Transthyretin Stabilizer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Transthyretin Stabilizer Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Transthyretin Stabilizer Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Transthyretin Stabilizer Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Transthyretin Stabilizer Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Transthyretin Stabilizer Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Transthyretin Stabilizer Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Transthyretin Stabilizer Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Transthyretin Stabilizer Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Transthyretin Stabilizer Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Transthyretin Stabilizer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Transthyretin Stabilizer Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Transthyretin Stabilizer Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Transthyretin Stabilizer Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Transthyretin Stabilizer Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Transthyretin Stabilizer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Transthyretin Stabilizer Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Transthyretin Stabilizer Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Transthyretin Stabilizer Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Transthyretin Stabilizer Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Transthyretin Stabilizer Sales (K Units) by Type (2020-2025)
 Table 51. Global Transthyretin Stabilizer Sales (K Units) by Type (2026-2031)
 Table 52. Global Transthyretin Stabilizer Sales Market Share by Type (2020-2025)
 Table 53. Global Transthyretin Stabilizer Sales Market Share by Type (2026-2031)
 Table 54. Global Transthyretin Stabilizer Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Transthyretin Stabilizer Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Transthyretin Stabilizer Revenue Market Share by Type (2020-2025)
 Table 57. Global Transthyretin Stabilizer Revenue Market Share by Type (2026-2031)
 Table 58. Global Transthyretin Stabilizer Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Transthyretin Stabilizer Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Transthyretin Stabilizer Sales (K Units) by Application (2020-2025)
 Table 61. Global Transthyretin Stabilizer Sales (K Units) by Application (2026-2031)
 Table 62. Global Transthyretin Stabilizer Sales Market Share by Application (2020-2025)
 Table 63. Global Transthyretin Stabilizer Sales Market Share by Application (2026-2031)
 Table 64. Global Transthyretin Stabilizer Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Transthyretin Stabilizer Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Transthyretin Stabilizer Revenue Market Share by Application (2020-2025)
 Table 67. Global Transthyretin Stabilizer Revenue Market Share by Application (2026-2031)
 Table 68. Global Transthyretin Stabilizer Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Transthyretin Stabilizer Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Inc. Company Information
 Table 71. Pfizer Inc. Description and Business Overview
 Table 72. Pfizer Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Inc. Transthyretin Stabilizer Product
 Table 74. Pfizer Inc. Recent Developments/Updates
 Table 75. Merck & Co. Company Information
 Table 76. Merck & Co. Description and Business Overview
 Table 77. Merck & Co. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck & Co. Transthyretin Stabilizer Product
 Table 79. Merck & Co. Recent Developments/Updates
 Table 80. AstraZeneca Plc. Company Information
 Table 81. AstraZeneca Plc. Description and Business Overview
 Table 82. AstraZeneca Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZeneca Plc. Transthyretin Stabilizer Product
 Table 84. AstraZeneca Plc. Recent Developments/Updates
 Table 85. GlaxoSmithKline Plc. Company Information
 Table 86. GlaxoSmithKline Plc. Description and Business Overview
 Table 87. GlaxoSmithKline Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. GlaxoSmithKline Plc. Transthyretin Stabilizer Product
 Table 89. GlaxoSmithKline Plc. Recent Developments/Updates
 Table 90. Corino Therapeutics Inc. Company Information
 Table 91. Corino Therapeutics Inc. Description and Business Overview
 Table 92. Corino Therapeutics Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Corino Therapeutics Inc. Transthyretin Stabilizer Product
 Table 94. Corino Therapeutics Inc. Recent Developments/Updates
 Table 95. Alnylam Pharmaceuticals Company Information
 Table 96. Alnylam Pharmaceuticals Description and Business Overview
 Table 97. Alnylam Pharmaceuticals Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Alnylam Pharmaceuticals Transthyretin Stabilizer Product
 Table 99. Alnylam Pharmaceuticals Recent Developments/Updates
 Table 100. Bellus Health Inc. Company Information
 Table 101. Bellus Health Inc. Description and Business Overview
 Table 102. Bellus Health Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bellus Health Inc. Transthyretin Stabilizer Product
 Table 104. Bellus Health Inc. Recent Developments/Updates
 Table 105. Ionis Pharmaceuticals, Inc. Company Information
 Table 106. Ionis Pharmaceuticals, Inc. Description and Business Overview
 Table 107. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product
 Table 109. Ionis Pharmaceuticals, Inc. Recent Developments/Updates
 Table 110. Proclara Bioscience Company Information
 Table 111. Proclara Bioscience Description and Business Overview
 Table 112. Proclara Bioscience Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Proclara Bioscience Transthyretin Stabilizer Product
 Table 114. Proclara Bioscience Recent Developments/Updates
 Table 115. Arturus Therapeutics Company Information
 Table 116. Arturus Therapeutics Description and Business Overview
 Table 117. Arturus Therapeutics Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Arturus Therapeutics Transthyretin Stabilizer Product
 Table 119. Arturus Therapeutics Recent Developments/Updates
 Table 120. Prothena Corporation Plc. Company Information
 Table 121. Prothena Corporation Plc. Description and Business Overview
 Table 122. Prothena Corporation Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Prothena Corporation Plc. Transthyretin Stabilizer Product
 Table 124. Prothena Corporation Plc. Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Transthyretin Stabilizer Distributors List
 Table 128. Transthyretin Stabilizer Customers List
 Table 129. Transthyretin Stabilizer Market Trends
 Table 130. Transthyretin Stabilizer Market Drivers
 Table 131. Transthyretin Stabilizer Market Challenges
 Table 132. Transthyretin Stabilizer Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Transthyretin Stabilizer
 Figure 2. Global Transthyretin Stabilizer Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Transthyretin Stabilizer Market Share by Type: 2024 & 2031
 Figure 4. Diflunisal Product Picture
 Figure 5. Tafamidis Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Transthyretin Stabilizer Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Transthyretin Stabilizer Market Share by Application: 2024 & 2031
 Figure 9. Hospital Pharmacies
 Figure 10. Retail Pharmacies
 Figure 11. Drug Stores
 Figure 12. Online Pharmacies
 Figure 13. Others
 Figure 14. Global Transthyretin Stabilizer Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Transthyretin Stabilizer Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Transthyretin Stabilizer Sales (2020-2031) & (K Units)
 Figure 17. Global Transthyretin Stabilizer Average Price (US$/Unit) & (2020-2031)
 Figure 18. Transthyretin Stabilizer Report Years Considered
 Figure 19. Transthyretin Stabilizer Sales Share by Manufacturers in 2024
 Figure 20. Global Transthyretin Stabilizer Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Transthyretin Stabilizer Players: Market Share by Revenue in Transthyretin Stabilizer in 2024
 Figure 22. Transthyretin Stabilizer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Transthyretin Stabilizer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Transthyretin Stabilizer Sales Market Share by Country (2020-2031)
 Figure 25. North America Transthyretin Stabilizer Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Transthyretin Stabilizer Sales Market Share by Country (2020-2031)
 Figure 29. Europe Transthyretin Stabilizer Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Transthyretin Stabilizer Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Transthyretin Stabilizer Revenue Market Share by Region (2020-2031)
 Figure 37. China Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Transthyretin Stabilizer Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Transthyretin Stabilizer Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Transthyretin Stabilizer Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Transthyretin Stabilizer Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Transthyretin Stabilizer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Transthyretin Stabilizer by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Transthyretin Stabilizer by Type (2020-2031)
 Figure 59. Global Transthyretin Stabilizer Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Transthyretin Stabilizer by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Transthyretin Stabilizer by Application (2020-2031)
 Figure 62. Global Transthyretin Stabilizer Price (US$/Unit) by Application (2020-2031)
 Figure 63. Transthyretin Stabilizer Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024
Global Thyroglobulin ELISA Kits Market Research Report 2024
Global Tafamidis Meglumine Soft Capsules Market Research Report 2024
Global Transthyretin Tetramer Stabilizer Drugs Market Research Report 2024
Global Transthyretin TTR Modulators Market Research Report 2024
Global Drugs for Transthyretin Amyloid Cardiomyopathy Market Research Report 2024
Global Transthyretin ELISA Kits Market Research Report 2024
Global Hereditary Transthyretin Amyloidosis HATTR Market Research Report 2024
Global Treatment of Hereditary Transthyretin Amyloid Neuropathy ATTRv PN Market Research Report 2024
Transthyretin amyloid cardiomyopathy ATTR CM Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transthyretin Amyloidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tafamidis Drugs Market Research Report 2024
Global Transthyretin Market Research Report 2024
Global Tafamidis API Market Research Report 2024
Global TTR ELISA Kits Market Research Report 2024
Global Familial Amyloid Polyneuropathy Therapeutic Market Research Report 2025
Global Monomer Stabilizers Market Research Report 2025
Global Thyroxine T4 Market Research Report 2025
Global Antithyroid Preparations Market Research Report 2024
Global Thyrogen Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions